Skip to content

Clinical trials

Phase 2 Carcinoma, Non-Small-Cell Lung trials in Ireland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2 Country / region: Ireland Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20071
20092
20101
20121
20131
20152
20171
20183
20201
20211
20221
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting3
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cancer Trials Ireland4
ETOP IBCSG Partners Foundation3
Bristol-Myers Squibb2
Incyte Corporation2
AbbVie1
Amgen1
AstraZeneca1
Bayer1
Eli Lilly and Company1
Merck KGaA, Darmstadt, Germany1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung19
Lung Neoplasms9
Neoplasms4
Neoplasm Metastasis3
Adenocarcinoma of Lung1
Biliary Tract Neoplasms1
Breast Neoplasms1
Colorectal Neoplasms1
Melanoma1
Pleural Effusion, Malignant1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

  • OPTIMISE Lung SABR NCT07777614Status changeNot yet recruiting to RecruitingOctober 18, 2026

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.